Enjoy complimentary customisation on priority with our Enterprise License!
The alpha lactalbumin market size is forecast to increase by USD 254.3 million at a CAGR of 6.8% between 2023 and 2028. The market is experiencing significant growth due to the increasing health consciousness among parents, leading them to prioritize nutritious and high-quality infant formula. Alpha lactalbumin, a major protein component of human milk, offers numerous health benefits for infants, including improved immune system development and enhanced digestive health. Additionally, the expanding applications of alpha lactalbumin in various industries, such as food and beverages, pharmaceuticals, and cosmetics, is driving market growth. However, the market faces challenges from the declining global birth rates, which may impact the demand for infant formula. Despite this, the market is expected to continue its upward trajectory, fueled by ongoing research and development efforts to create innovative alpha lactalbumin-based products.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Application
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.